Quick view Biovision | AMG-337 | B3317 AMG-337 is a potent and selective inhibitor of c-Met kinase activity (IC50 = 1 nM) and adaptor protein Gab-1 phosphorylation, that subsequently blocks downstream PI3K and MAPK pathways. It has been... MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare
Quick view Biovision | EZSolution™ PF-04217903 | B2628 A 10 mM (5 mg in 1.34 ml) of the ATP-competitive c-Met kinase inhibitor (Cat. No. B2062) in anhydrous DMSOA 10 mM (5 mg in 1.34 ml) of the ATP-competitive c-Met kinase inhibitor (Cat. No. B2062) in... MSRP: Now: NULL288.00 Add to Cart Compare Quick view Biovision | Glumetinib | B2561 Glumetinib (SCC-244) is a potent and highly selective inhibitor of c-Met kinase (IC₅₀ = 0.42 nM). Glumetinib displays subnanomolar potency against c-Met kinase activity and high selectivity versus... MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare Quick view Biovision | SAR-125844 | B2510 SAR-125844 is a potent, selective, reversible and ATP-competitive c-MET inhibitor, with an IC₅₀ of 4.2 nM. Displays inhibition of MET autophosphorylation in cell-based assays. Upon intravenous... MSRP: Was: Now: NULL205.00 - NULL533.00 Choose Options Compare Quick view Biovision | SU 11274 | 1938 A specific, ATP-competitive small molecule inhibitor of the catalytic activity of Met. Displays selectivity for Met enzyme versus a panel of other tyrosine kinases with the following IC₅₀ values: Met... MSRP: Was: Now: NULL320.00 - NULL1,009.00 Choose Options Compare Quick view Biovision | Carbozantinib | 1935 Cell-permeable. A potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects.Carbozantinib is a potent... MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare Quick view Biovision | BMS-777607 | 2455 A potent, selective and ATP-competitive Met kinase superfamily inhibitor (IC₅₀ = 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM for c-Met, Axl, RON, and Tyro-3, respectively). it was >40-fold selective for Met... MSRP: Was: Now: NULL288.00 - NULL861.00 Choose Options Compare Quick view Biovision | Altiratinib | 9563 Altiratinib is a selective and highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinases with potential anticancer activity. It effectively reduces tumor burden in vivo and blocks c-MET... MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare Quick view Biovision | Crizotinib | 1934 A specific, ATP-competitive, small-molecule inhibitor of the receptor tyrosine kinases (RTKs) c-Met and anaplastic lymphoma kinase (ALK). Iinhibits tyrosine phosphorylation of activated ALK at... MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare Quick view Biovision | Tivantinib | B1546 Tivantinib (ARQ-197) is a potent, cell-permeable inhibitor of c-Met with potential antineoplastic activity. Tivantinib binds to the c-Met protein and disrupts c-Met signal transduction pathways,... MSRP: Was: Now: NULL222.00 - NULL631.00 Choose Options Compare Quick view Biovision | JNJ-38877605 | B2063 JNJ-38877605 is a potent c-MET tyrosine kinase inhibitor with potential anti-neoplastic activity. It is potent (IC₅₀ values of 4 nM and 50 nM for c-MET enzyme and Phospho-MET respectively). Displays... MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare Quick view Biovision | Golvatinib | 2655 Golvatinib ( E7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with... MSRP: Was: Now: NULL320.00 - NULL984.00 Choose Options Compare Quick view Biovision | AMG-208 | 2553 AMG-708 is a selective small-molecule inhibitor (IC₅₀ = 9.3 nM) of the proto-oncogene c-Met with potential antineoplastic activity. AMG 208 inhibits the ligand-dependent and ligand-independent... MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare Quick view Biovision | PF-04217903 | B2062 PF-04217903 is a novel ATP-competitive small-molecule inhibitor of c-Met kinase. PF-04217903 displays more than 1,000-fold selectivity for c-Met compared with more than 150 kinases. PF-04217903... MSRP: Was: Now: NULL271.00 - NULL828.00 Choose Options Compare Quick view Biovision | PHA-665752 | B2057 PHA-665752 is a potent, selective and ATP-competitive inhibitor of MET kinase (IC₅₀ values are 9, 68, 200, 1400, 3000, 3800 and 6000 nM for MET, Ron, Flk-1, c-abl, FGFR1, EGFR and c-src respectively... MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare Quick view Biovision | Foretinib | 9476 Foretinib is an ATP-competitive multi-kinase inhibitor that suppresses the activity of hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor-2 (VEGFR-2). In... MSRP: Was: Now: NULL239.00 - NULL697.00 Choose Options Compare Quick view Details Biovision | AMG-337 | B3317 MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare Quick view Details Biovision | EZSolution™ PF-04217903 | B2628 MSRP: Now: NULL288.00 Add to Cart Compare Quick view Details Biovision | Glumetinib | B2561 MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare Quick view Details Biovision | SAR-125844 | B2510 MSRP: Was: Now: NULL205.00 - NULL533.00 Choose Options Compare Quick view Details Biovision | SU 11274 | 1938 MSRP: Was: Now: NULL320.00 - NULL1,009.00 Choose Options Compare Quick view Details Biovision | Carbozantinib | 1935 MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare Quick view Details Biovision | BMS-777607 | 2455 MSRP: Was: Now: NULL288.00 - NULL861.00 Choose Options Compare Quick view Details Biovision | Altiratinib | 9563 MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare Quick view Details Biovision | Crizotinib | 1934 MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare Quick view Details Biovision | Tivantinib | B1546 MSRP: Was: Now: NULL222.00 - NULL631.00 Choose Options Compare Quick view Details Biovision | JNJ-38877605 | B2063 MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare Quick view Details Biovision | Golvatinib | 2655 MSRP: Was: Now: NULL320.00 - NULL984.00 Choose Options Compare Quick view Details Biovision | AMG-208 | 2553 MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare Quick view Details Biovision | PF-04217903 | B2062 MSRP: Was: Now: NULL271.00 - NULL828.00 Choose Options Compare Quick view Details Biovision | PHA-665752 | B2057 MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare Quick view Details Biovision | Foretinib | 9476 MSRP: Was: Now: NULL239.00 - NULL697.00 Choose Options Compare Compare Selected
Quick view Biovision | Glumetinib | B2561 Glumetinib (SCC-244) is a potent and highly selective inhibitor of c-Met kinase (IC₅₀ = 0.42 nM). Glumetinib displays subnanomolar potency against c-Met kinase activity and high selectivity versus... MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare
Quick view Biovision | SAR-125844 | B2510 SAR-125844 is a potent, selective, reversible and ATP-competitive c-MET inhibitor, with an IC₅₀ of 4.2 nM. Displays inhibition of MET autophosphorylation in cell-based assays. Upon intravenous... MSRP: Was: Now: NULL205.00 - NULL533.00 Choose Options Compare
Quick view Biovision | SU 11274 | 1938 A specific, ATP-competitive small molecule inhibitor of the catalytic activity of Met. Displays selectivity for Met enzyme versus a panel of other tyrosine kinases with the following IC₅₀ values: Met... MSRP: Was: Now: NULL320.00 - NULL1,009.00 Choose Options Compare
Quick view Biovision | Carbozantinib | 1935 Cell-permeable. A potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects.Carbozantinib is a potent... MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare
Quick view Biovision | BMS-777607 | 2455 A potent, selective and ATP-competitive Met kinase superfamily inhibitor (IC₅₀ = 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM for c-Met, Axl, RON, and Tyro-3, respectively). it was >40-fold selective for Met... MSRP: Was: Now: NULL288.00 - NULL861.00 Choose Options Compare
Quick view Biovision | Altiratinib | 9563 Altiratinib is a selective and highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinases with potential anticancer activity. It effectively reduces tumor burden in vivo and blocks c-MET... MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare
Quick view Biovision | Crizotinib | 1934 A specific, ATP-competitive, small-molecule inhibitor of the receptor tyrosine kinases (RTKs) c-Met and anaplastic lymphoma kinase (ALK). Iinhibits tyrosine phosphorylation of activated ALK at... MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare
Quick view Biovision | Tivantinib | B1546 Tivantinib (ARQ-197) is a potent, cell-permeable inhibitor of c-Met with potential antineoplastic activity. Tivantinib binds to the c-Met protein and disrupts c-Met signal transduction pathways,... MSRP: Was: Now: NULL222.00 - NULL631.00 Choose Options Compare
Quick view Biovision | JNJ-38877605 | B2063 JNJ-38877605 is a potent c-MET tyrosine kinase inhibitor with potential anti-neoplastic activity. It is potent (IC₅₀ values of 4 nM and 50 nM for c-MET enzyme and Phospho-MET respectively). Displays... MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare
Quick view Biovision | Golvatinib | 2655 Golvatinib ( E7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with... MSRP: Was: Now: NULL320.00 - NULL984.00 Choose Options Compare
Quick view Biovision | AMG-208 | 2553 AMG-708 is a selective small-molecule inhibitor (IC₅₀ = 9.3 nM) of the proto-oncogene c-Met with potential antineoplastic activity. AMG 208 inhibits the ligand-dependent and ligand-independent... MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare
Quick view Biovision | PF-04217903 | B2062 PF-04217903 is a novel ATP-competitive small-molecule inhibitor of c-Met kinase. PF-04217903 displays more than 1,000-fold selectivity for c-Met compared with more than 150 kinases. PF-04217903... MSRP: Was: Now: NULL271.00 - NULL828.00 Choose Options Compare
Quick view Biovision | PHA-665752 | B2057 PHA-665752 is a potent, selective and ATP-competitive inhibitor of MET kinase (IC₅₀ values are 9, 68, 200, 1400, 3000, 3800 and 6000 nM for MET, Ron, Flk-1, c-abl, FGFR1, EGFR and c-src respectively... MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare
Quick view Biovision | Foretinib | 9476 Foretinib is an ATP-competitive multi-kinase inhibitor that suppresses the activity of hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor-2 (VEGFR-2). In... MSRP: Was: Now: NULL239.00 - NULL697.00 Choose Options Compare
Quick view Details Biovision | AMG-337 | B3317 MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare
Quick view Details Biovision | EZSolution™ PF-04217903 | B2628 MSRP: Now: NULL288.00 Add to Cart Compare Quick view Details Biovision | Glumetinib | B2561 MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare Quick view Details Biovision | SAR-125844 | B2510 MSRP: Was: Now: NULL205.00 - NULL533.00 Choose Options Compare Quick view Details Biovision | SU 11274 | 1938 MSRP: Was: Now: NULL320.00 - NULL1,009.00 Choose Options Compare Quick view Details Biovision | Carbozantinib | 1935 MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare Quick view Details Biovision | BMS-777607 | 2455 MSRP: Was: Now: NULL288.00 - NULL861.00 Choose Options Compare Quick view Details Biovision | Altiratinib | 9563 MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare Quick view Details Biovision | Crizotinib | 1934 MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare Quick view Details Biovision | Tivantinib | B1546 MSRP: Was: Now: NULL222.00 - NULL631.00 Choose Options Compare Quick view Details Biovision | JNJ-38877605 | B2063 MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare Quick view Details Biovision | Golvatinib | 2655 MSRP: Was: Now: NULL320.00 - NULL984.00 Choose Options Compare Quick view Details Biovision | AMG-208 | 2553 MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare Quick view Details Biovision | PF-04217903 | B2062 MSRP: Was: Now: NULL271.00 - NULL828.00 Choose Options Compare Quick view Details Biovision | PHA-665752 | B2057 MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare Quick view Details Biovision | Foretinib | 9476 MSRP: Was: Now: NULL239.00 - NULL697.00 Choose Options Compare Compare Selected
Quick view Details Biovision | Glumetinib | B2561 MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare
Quick view Details Biovision | SAR-125844 | B2510 MSRP: Was: Now: NULL205.00 - NULL533.00 Choose Options Compare
Quick view Details Biovision | SU 11274 | 1938 MSRP: Was: Now: NULL320.00 - NULL1,009.00 Choose Options Compare
Quick view Details Biovision | Carbozantinib | 1935 MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare
Quick view Details Biovision | BMS-777607 | 2455 MSRP: Was: Now: NULL288.00 - NULL861.00 Choose Options Compare
Quick view Details Biovision | Altiratinib | 9563 MSRP: Was: Now: NULL288.00 - NULL894.00 Choose Options Compare
Quick view Details Biovision | Crizotinib | 1934 MSRP: Was: Now: NULL296.00 - NULL910.00 Choose Options Compare
Quick view Details Biovision | Tivantinib | B1546 MSRP: Was: Now: NULL222.00 - NULL631.00 Choose Options Compare
Quick view Details Biovision | JNJ-38877605 | B2063 MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare
Quick view Details Biovision | Golvatinib | 2655 MSRP: Was: Now: NULL320.00 - NULL984.00 Choose Options Compare
Quick view Details Biovision | AMG-208 | 2553 MSRP: Was: Now: NULL354.00 - NULL1,148.00 Choose Options Compare
Quick view Details Biovision | PF-04217903 | B2062 MSRP: Was: Now: NULL271.00 - NULL828.00 Choose Options Compare
Quick view Details Biovision | PHA-665752 | B2057 MSRP: Was: Now: NULL303.00 - NULL959.00 Choose Options Compare
Quick view Details Biovision | Foretinib | 9476 MSRP: Was: Now: NULL239.00 - NULL697.00 Choose Options Compare